4893 items matching your search terms.

Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer

Joshua, AM Nordman, I Venkataswaran, R Clarke, S Stockler, MR Boyer, MJ

Developing evidence-based practice in diabetes care: FIELD, a landmark trial

Keech, AC

The need for a large-scale trial of fibrate therapy in diabetes: FIELD rationale and design

Keech, AC

Urinary albumin levels in the normal range determine arterial wall thickness in adults with type 2 diabetes: a FIELD substudy

Keech, AC Grieve, SM Patel, A Griffiths, K Skilton, M Watts, GF Marwick, TH Groshens, M Celermajer, DS for the FIELD Vascular Study Investigators,

The importance of PPAR alpha agonists in the treatment of metabolic syndrome and type II diabetes

Keech, AC; Best, J; Barter, P; Scott, R; Simes, R.J; Taskinen, M-R

Rationale and design for a large-scale study of fibrate therapy in diabetes: the FIELD trial

Keech, AC; Best, JD; Scott, RS; Barter, PJ; Simes, RJ; Forder, P; Taskinen, M-R

FIELD study: a large scale trial of fibrate therapy in diabetes

Keech, A.C.

The need for a large-scale trial of fibrate therapy in diabetes: FIELD rationale and design

Keech, A.C.

Practical aspects of epidemiological studies in the Asia-Pacific region

Keech, A.C.

Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: A FIELD substudy

Keech, A. C. Grieve, S. M. Patel, A. Griffiths, K. Skiltont, M. Watts, G. F. Marwick, T. H. Groshens, M. Celermajer, D. S.
DIABETIC MEDICINE, 2005     DOI:10.1111/j.1464-5491.2005.01688.x

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: Baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

Keech, A. C. Scott, R. Best, J. Forder, P. Taskinen, M. R. Simes, J. Barter, P. Colman, P. d'Emden, M. Davis, T. Drury, P. Ehnholm, C. Glasziou, P. Hunt, D. Kesaniemi, Y. A. Laakso, M. Simes, R. J. Sullivan, D. Whiting, M. Ansquer, J. C. Fraitag, B. Anderson, N. Hankey, G. Lehto, S. Mann, S. Romo, M. Li, L. P. Hennekens, C. MacMahon, S. Pocock, S. Tonkin, A. Wilhelmsen, L. Akauola, H. Alford, F. Beinart, I. Bohra, S. Boyages, S. Connor, H. Darnell, D. Davoren, P. Lepre, F. De Looze, F. Duffield, A. Fassett, R. Flack, J. Fulcher, G. Grant, S. Hamwood, S. Harmelin, D. Jackson, R. Jeffries, W. Kamp, M. Kritharides, L. Mahar, L. McCann, V. McIntyre, D. Moses, R. Newnham, H. Nicholson, G. O'Brien, R. Park, K. Petrovsky, N. Phillips, P. Pinn, G. Simmons, D. Stanton, K. Stuckey, B. Sullivan, D. R. Suranyi, M. Suthers, M. Tan, Y. Templer, M. Topliss, D. Waites, J. H. Watts, G. Welborn, T. Wyndham, R. Haapamaki, H. Kesaniemi, A. Laakso, M. Lahtela, J. Levanen, H. Saltevo, J. Sodervik, H. Taskinen, M. Vanhala, M. Baker, J. Burton, A. Dixon, P. Doran, J. Drury, P. Dunn, P. Graham, N. Hamer, A. Hedley, J. Lloyd, J. Manning, P. McPherson, I. Morris, S.
CARDIOVASCULAR DIABETOLOGY, 2005     DOI:10.1186/1475-2840-4-13

Risk factors for 10-year coronary heart disease mortality in patients with prior acute coronary syndromes: the LIPID cohort. The LIPID study investigators

Kirby, A; Simes, J; Pater, H; Keech, A; Hunt, D; White, H; West, M; Nestel, P; Tonkin, A

Achieving equal standards in medical student education: is a national exit examination the answer?

Koczwara, B Tattersall, MH Barton, MB Coventry, BJ Dewar, JM Millar, JL Olver, IN Schwarz, MA Starmer, DL Turner, DR Stockler, MR

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials

Labinaz, M; Mathias, J; Pieper, K; Granger, CB; Lincoff, AM; Moliterno, DJ; Van de Werf, F; Simes, J; White, HD; Simoons, ML; Califf, RM; Topol, EJ; Armstrong, PW; Harrington, RA

Presenting symptoms of epithelial ovarian cancer

Lataifeh, I Marsden, DE Robertson, G Gebski, V Hacker, NF